Company intelligence / Profile preview
Tagworks Pharmaceuticals
- Ownership
- Private
- Development stage
- Preclinical
Overview
Tagworks’ lead candidate TGW101, a first-in-class ADC targeting TAG72 with an MMAE payload using Click-to-Release linker chemistry, has entered Phase I trials to assess safety/tolerability and determine dosing. Preclinical data showed favorable safety and durable anti-tumor responses. The company’s approach enables targeted payload activation at the tumor site without requiring internalization by cancer cells—a limitation of conventional ADCs—potentially expanding the treatable patient population.
- Therapeutic areas
- Oncology
- Modalities
- Antibody-drug conjugates (ADCs)RadiopharmaceuticalsSmall molecules (platform compatible)Peptides (platform compatible)Immunomodulators
- Industry
- Biotech
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Tagworks Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tagworks Pharmaceuticals.